Regional Monitoring EECA
by ECUO PLWH
Showing 1-876 of 876 items.
Excel
#CountrySource of financingManufacturerTradenameINNFormPrice per unit ($)Units in purchaseUnits in packagePrice per package ($)Packages in purchasePrice per purchase ($)DistributorYearPurchase dateDelivery dateRegisteredIn the list of main (vital) medicationsWHO prequalification
1Republic of PolandGovernmentGlaxoSmithKlineZiagenAbacavir (ABC)20mg/ml oral solution 240ml69.3950169.39503469.5Krajowe Centrum ds. AIDS2016YesYesNot specified
2UkraineGovernmentHetero labs Ltd.AbacavirAbacavir (ABC)20mg/ml oral solution 240ml9.15496319.15496345411.452016YesYesYes
3Kyrgyz RepublicGlobal FundHetero labs Ltd.Abacavir (ABC)300mg tab0.2125211806012.753534500.75UNDP/UNICEF20152014-12-312015-12-30Not specifiedNot specifiedNot specified
4Republic of KazakhstanGovernmentGlaxoSmithKlineZiagenAbacavir (ABC)20mg/ml oral solution 240ml71.21171.2171.22016YesNot specifiedNot specified
5Republiс of AzerbaijanGovernmentGlaxoSmithKlineAbacavir (ABC)300mg tab0.6048285606036.2947617274.042015YesYesNot specified
6Republic of PolandGovernmentGlaxoSmithKlineZiagenAbacavir (ABC)20mg/ml oral solution 240ml69.39100169.391006939Krajowe Centrum ds. AIDS2016Not specifiedNot specifiedNot specified
7Russian FederationGovernmentViiV HealthcareZiagenAbacavir (ABC)20mg/ml oral solution 240ml45.621875145.6218759975002015Not specifiedNot specifiedNot specified
8UkraineGovernmentViiV HealthcareAbacavir (ABC)20mg/ml oral solution 240ml0.08119101510.08119101595281.22015Not specifiedNot specifiedNot specified
9GeorgiaGlobal FundAurobindo Pharma Ltd.Abacavir (ABC)20mg/ml oral solution 240ml6.834516.8345307.35partnership for supply. chain management (PFSCM)2016YesYesNot specified
10Republic of TajikistanGlobal FundAurobindo Pharma Ltd.Abacavir (ABC)20mg/ml oral solution 240ml10.51044110.5104410962UNDP/UNICEF2016Not specifiedYesNot specified
11Republiс of AzerbaijanGovernmentAurobindo Pharma Ltd.Abacavir (ABC)20mg/ml oral solution 240ml37.44533137.4453319955.522015YesYesNot specified
12Republic of UzbekistanGlobal FundAurobindo Pharma Ltd.Abacavir (ABC)20mg/ml oral solution 240ml12-112--2015Not specifiedNot specifiedNot specified
13Russian FederationGovernmentPharmasyntezOlitidAbacavir (ABC)600mg tab1.2167595030365586520111402016Not specifiedYesNot specified
14Republic of PolandGovernmentViiV HealthcareZiagenAbacavir (ABC)20mg/ml oral solution 240ml72.544172.54431902015Not specifiedNot specifiedNot specified
15Russian FederationGovernmentPharmasyntezOlitidAbacavir (ABC)300mg tab1.1333264384060684406429963522015Not specifiedNot specifiedNot specified
16Republic of LatviaGovernmentViiV HealthcareZiagenAbacavir (ABC)20mg/ml oral solution 240ml66.29-166.29--2015Not specifiedNot specifiedNot specified
17Republic of TajikistanGlobal FundAurobindo Pharma Ltd.Abacavir (ABC)300mg tab0.23336060141142015Not specifiedNot specifiedNot specified
18Russian FederationGovernmentPharmasyntezOlitidAbacavir (ABC)300mg tab0.314724606018245414417382016YesYesNot specified
19GeorgiaGlobal FundHetero labs Ltd.Abacavir (ABC)20mg/ml oral solution 240ml7.521617.52161620partnership for supply. chain management (PFSCM)2015Not specifiedNot specifiedNot specified
20UkrainePEPFARMYLAN LABORATORIES LTDAbacavir (ABC)Abacavir (ABC)300mg tab0.154563040609.24938486708.162016YesNot specifiedNot specified
21Republic of UzbekistanGlobal FundAurobindo Pharma Ltd.AbacavirAbacavir (ABC)300mg tab0.1848606011.09111.092016YesYesYes
22UkraineGlobal FundGlaxoSmithKlineAbacavir (ABC)300mg tab0.425606025.5125.52015Not specifiedNot specifiedNot specified
23Russian FederationGovernmentViiV HealthcareZiagenAbacavir (ABC)300mg tab1.09328209206065.5913682897402.382015Not specifiedNot specifiedNot specified
24Republic of PolandGovernmentViiV HealthcareZiagenAbacavir (ABC)300mg tab3.81253000060228.755001143752015Not specifiedNot specifiedNot specified
25Republic of KazakhstanGovernmentKievmedpreparat, UkraineAbacavir (ABC)20mg/ml oral solution 240ml119.485961119.4859671210.082015Not specifiedNot specifiedNot specified
26Republic of BelarusGlobal FundHetero labs Ltd.Abacavir (ABC)300mg tab0.18482991006011.09498555283.65UNICEF Supply Division20152015-05-24Not specifiedNot specifiedNot specified
27Republic of PolandGovernmentGlaxoSmithKlineZiagenAbacavir (ABC)20mg/ml oral solution 240ml69.3950169.39503469.5Krajowe Centrum ds. AIDS2016YesYesNot specified
28Republic of BelarusGlobal FundGlaxoSmithKlineAbacavir (ABC)20mg/ml oral solution 240ml14.99165114.991652473.35UNDP/UNICEF2016YesNoNot specified
29Russian FederationGovernmentR-FarmAbacavirAbacavir (ABC)300mg tab0.2746310806016.4410518172915.922016YesYesNot specified
30GeorgiaGlobal FundMYLAN LABORATORIES LTDAbacavir (ABC)300mg tab0.1832129606010.992162373.84partnership for supply. chain management (PFSCM)2015Not specifiedNot specifiedNot specified
31Republic of LatviaGovernmentViiv Healthcare UK LimitedZiagenAbacavir (ABC)20mg/ml oral solution 240ml82.6282182.62826774.84National Health Service (NHC)2016Not specifiedNot specifiedNot specified
32Kyrgyz RepublicGlobal FundHetero labs Ltd.Abacavir (ABC)300mg tab0.165338700609.926456398.4UNDP/UNICEF2016NoNoNot specified
33Republic of PolandGovernmentViiV HealthcareZiagenAbacavir (ABC)300mg tab3.81253900060228.75650148687.52015Not specifiedNot specifiedNot specified
34Republic of KazakhstanGovernmentGlaxoSmithKlineZiagenAbacavir (ABC)300mg tab0.028360601.711.72016YesYesNot specified
35Republic of KazakhstanGovernmentMYLAN LABORATORIES LTDAbacavir (ABC)300mg tab0.04311091600602.58184860476938.812015Not specifiedNot specifiedNot specified
36UkraineGovernmentGlaxoSmithKlineAbacavir (ABC)300mg tab0.26828132406016.0913554218083.862015Not specifiedNot specifiedNot specified
37Republic of PolandGovernmentGlaxoSmithKlineZiagenAbacavir (ABC)150mg tab3.46673000060208500104000Krajowe Centrum ds. AIDS2016YesYesNot specified
38Republic of TajikistanGlobal FundViiV HealthcareAbacavir (ABC)20mg/ml oral solution 240ml8-18--2015Not specifiedNot specifiedNot specified
39UkraineGovernmentMYLAN LABORATORIES LTDAbacavir (ABC)Abacavir (ABC)300mg tab0.17828132406010.6913554144892.272016YesYesNot specified
40Republic of KazakhstanGovernmentAbdi Ibrahim Global FarmVirakarAbacavir (ABC)300mg tab0.032260601.9311.932016YesNot specifiedNot specified
41Republic of ArmeniaGlobal FundAurobindo Pharma Ltd.Abacavir (ABC)20mg/ml oral solution 240ml6.75216.75213.5VPP, through Partnership for Supply Chain Management (PFSCM)20152015-03-112015-10-14Not specifiedNot specifiedNot specified
42Republic of MoldovaGovernmentViiv Healthcare UK LimitedZiagenAbacavir (ABC)20mg/ml oral solution 240ml59.98114159.981146837.72Dita Estfarm SRL2015Not specifiedNot specifiedNot specified
43Republic of PolandGovernmentGlaxoSmithKlineZiagenAbacavir (ABC)300mg tab3.36271800060201.7630060528Krajowe Centrum ds. AIDS2016Not specifiedNot specifiedNot specified
44Russian FederationGovernmentDrugs technologyAbacavir-ABCAbacavir (ABC)300mg tab1.15965521206069.5410920275939072015Not specifiedNot specifiedNot specified
45Russian FederationGovernmentPharmasyntezOlitidAbacavir (ABC)600mg tab2.509760223203075.29200744151140162015Not specifiedNot specifiedNot specified
46Republic of ArmeniaGlobal FundAurobindo Pharma Ltd.Abacavir (ABC)300mg tab0.181717406010.929316.1partnership for supply. chain management (PFSCM)2016NoYesNot specified
47Republic of UzbekistanGlobal FundAurobindo Pharma Ltd.Abacavir (ABC)300mg tab0.1848606011.09111.092015Not specifiedNot specifiedNot specified
48Russian FederationGovernmentGlaxoSmithKlineZiagenAbacavir (ABC)20mg/ml oral solution 240ml36.8659136.865924251.22016YesYesNot specified
49Republic of BelarusGovernmentHetero Labs + ФарматехAbacavirAbacavir (ABC)300mg tab0.3667900840602215014330308Republican unitary enterprise "BELPHARMATSIYA"2016-02-18YesYesNo
50UkraineGlobal FundGlaxoSmithKlineZiagenAbacavir (ABC)300mg tab0.403711750406024.2219584474324.472016YesYesNot specified
51Republic of UzbekistanGlobal FundAurobindo Pharma Ltd.AbacavirAbacavir (ABC)20mg/ml oral solution 240ml1211121122016YesYesYes
52Republic of BelarusGovernmentHetero Labs + ФарматехAbacavir (ABC)300mg tab0.33429008406020.0515014301030.69Фарматех ЗАО2015Not specifiedNot specifiedNot specified
53Republic of PolandGovernmentViiV HealthcareZiagenAbacavir (ABC)300mg tab3.8125300060228.755011437.52015Not specifiedNot specifiedNot specified
54Russian FederationGovernmentPharmasyntezOlitidAbacavir (ABC)150mg tab0.6933180606041.630112521.62015Not specifiedNot specifiedNot specified
55Republic of LatviaGovernmentViiV HealthcareZiagenAbacavir (ABC)300mg tab3.47026060208.211208.212015Not specifiedNot specifiedNot specified
56Republic of TajikistanGlobal FundAurobindo Pharma Ltd.Abacavir (ABC)300mg tab0.1917180006011.53003450UNDP/UNICEF2016Not specifiedYesNot specified
57Republic of PolandGovernmentViiV HealthcareZiagenAbacavir (ABC)20mg/ml oral solution 240ml72.540172.54029002015Not specifiedNot specifiedNot specified
58Russian FederationGovernmentPharmasyntezOlitidAbacavir (ABC)300mg tab0.4981678206029.88279783574.362016YesYesNot specified
59Republic of PolandGovernmentViiV HealthcareZiagenAbacavir (ABC)20mg/ml oral solution 240ml72.5100172.510072502015Not specifiedNot specifiedNot specified
60Republic of ArmeniaGlobal FundMYLAN LABORATORIES LTDAbacavir (ABC)300mg tab0.1665420609.99769.93partnership for supply. chain management (PFSCM)2016NoYesNot specified
61Republic of KazakhstanGovernmentViiV HealthcareZiagenAbacavir (ABC)300mg tab0.0442343600602.6439060103118.42015Not specifiedNot specifiedNot specified
62Republic of ArmeniaGlobal FundCipla LtdAbacavir (ABC)300mg tab0.19569006011.71151345.5VPP, through Partnership for Supply Chain Management (PFSCM)20152015-03-112015-10-14Not specifiedNot specifiedNot specified
63Republic of LatviaGovernmentViiv Healthcare UK LimitedZiagenAbacavir (ABC)300mg tab3.98673840060239.2640153088National Health Service (NHC)2016Not specifiedNot specifiedNot specified
64Republic of TajikistanGlobal FundViiV HealthcareAbacavir+Lamivudine - FDC60mg+30mg tab0.083360605152015Not specifiedNot specifiedNot specified
65Republic of MoldovaGovernmentRanbaxy Laboratories LimitedAbacavir+Lamivudine - FDC60mg+30mg tab0.184355740305.53185810274.74Medeferent Grup SRLNot specifiedNot specifiedNot specified
66Republic of TajikistanGlobal FundAurobindo Pharma Ltd.Abacavir+Lamivudine - FDC600mg+300mg tab0.4667900003014300042000UNDP/UNICEF2016Not specifiedNot specifiedNot specified
67Republic of PolandGovernmentViiV HealthcareKivexaAbacavir+Lamivudine - FDC600mg+300mg tab14.1667660003042522009350002015Not specifiedNot specifiedNot specified
68Republic of PolandGovernmentViiV HealthcareKivexaAbacavir+Lamivudine - FDC600mg+300mg tab14.166719500030425650027625002015Not specifiedNot specifiedNot specified
69Republic of ArmeniaGlobal FundMYLAN LABORATORIES LTDAbacavir+Lamivudine - FDC600mg+300mg tab0.416382203012.492743422.26partnership for supply. chain management (PFSCM)2016NoYesNot specified
70UkraineGlobal FundGlaxoSmithKlineKivexaAbacavir+Lamivudine - FDC600mg+300mg tab0.9696291003029.0720970609597.882016YesYesNot specified
71Republic of ArmeniaGlobal FundMYLAN LABORATORIES LTDAbacavir+Lamivudine - FDC600mg+300mg tab0.43331590301353689VPP, through Partnership for Supply Chain Management (PFSCM)20152015-03-112015-10-14Not specifiedNot specifiedNot specified
72Kyrgyz RepublicGlobal FundAurobindo Pharma Ltd.Abacavir+Lamivudine - FDC600mg+300mg tab0.5167-3015.5--UNDP/UNICEF20152014-12-312015-12-30Not specifiedNot specifiedNot specified
73Republic of MoldovaGlobal FundMYLAN LABORATORIES LTDAbacavir+Lamivudine - FDC600mg+300mg tab0.565101103016.953375712.15IDA Foundation2016Not specifiedNot specifiedNot specified
74Russian FederationGovernmentViiV HealthcareKivexaAbacavir+Lamivudine - FDC600mg+300mg tab4.002436197030120.06145399174566042015Not specifiedNot specifiedNot specified
75Republic of LithuaniaGovernmentViiv Healthcare UK LimitedKivexaAbacavir+Lamivudine - FDC600mg+300mg tab11.13733030334.121334.12Viiv Healthcare UK Limited2015Not specifiedYesNot specified
76UkraineGovernmentAurobindo Pharma Ltd.Abacavir+LamivudimAbacavir+Lamivudine - FDC600mg+300mg tab0.40431719303012.13573169517.032016YesYesYes
77Republic of PolandGovernmentSandozAbacavir + Lamivudine SandozAbacavir+Lamivudine - FDC600mg+300mg tab8.37535100030251.261700427142Krajowe Centrum ds. AIDS2016Not specifiedNot specifiedNot specified
78Republic of MoldovaGlobal FundHetero labs Ltd.Abacavir+Lamivudine - FDC600mg+300mg tab0.56550403016.951682847.62015Not specifiedYesNot specified
79Republic of LithuaniaInsurance FundTeva BVKivexaAbacavir+Lamivudine - FDC600mg+300mg tab7.57473030227.241227.242016YesYesYes
80GeorgiaGlobal FundGlaxoSmithKlineAbacavir+Lamivudine - FDC600mg+300mg tab1.9667494403059164897232partnership for supply. chain management (PFSCM)2016YesYesNot specified
81Russian FederationGovernmentViiV HealthcareKivexaAbacavir+Lamivudine - FDC600mg+300mg tab1.83600030541200648002016YesYesNot specified
82Republiс of AzerbaijanGovernmentViiV HealthcareAbacavir+Lamivudine - FDC600mg+300mg tab1.7167219603051.5732376982015YesYesNot specified
83Republic of PolandGovernmentViiv Healthcare UK LimitedKivexaAbacavir+Lamivudine - FDC600mg+300mg tab14.166718000304256002550002015Not specifiedNot specifiedNot specified
84Republic of MoldovaGlobal FundCipla LtdAbacavir+Lamivudine - FDC60mg+30mg tab0.1221480607.23582577.62015Not specifiedYesNot specified
85Kyrgyz RepublicGlobal FundCipla LtdAbamune-L BabyAbacavir+Lamivudine - FDC60mg+30mg tab0.0833282060547235UNDP/UNICEF20152014-12-312015-12-30Not specifiedNot specifiedNot specified
86Republic of TajikistanGlobal FundAurobindo Pharma Ltd.Abacavir+Lamivudine - FDC60mg+30mg tab0.0833248400605414020700UNDP/UNICEF2016Not specifiedNot specifiedNot specified
87Republic of TajikistanGlobal FundViiV HealthcareAbacavir+Lamivudine - FDC600mg+300mg tab0.5167303015.5115.52015Not specifiedNot specifiedNot specified
88Republic of MoldovaGovernmentViiv Healthcare UK LimitedZiagenAbacavir+Lamivudine - FDC600mg+300mg tab5.81672487030174.5829144660.5Dita Estfarm SRLNot specifiedNot specifiedNot specified
89Republic of MoldovaGlobal FundHetero labs Ltd.Abacavir+Lamivudine - FDC600mg+300mg tab0.56550703016.951692864.55IDA Foundation2015Not specifiedYesNot specified
90UkraineGovernmentCipla LtdAbacavir+Lamivudine - FDC60mg+30mg tab0.097264440605.8310746261.422015Not specifiedNot specifiedNot specified
91UkrainePEPFARMYLAN LABORATORIES LTDAbacavir (ABC)Abacavir+Lamivudine - FDC600mg+300mg tab0.37339664803011.232216360819.192016YesNot specifiedNot specified
92Republic of LatviaGovernmentViiV HealthcareKivexaAbacavir+Lamivudine - FDC600mg+300mg tab11.6193030348.571348.572015Not specifiedNot specifiedNot specified
93Republic of PolandGovernmentGlaxoSmithKlineKivexaAbacavir+Lamivudine - FDC600mg+300mg tab12.88213800030386.4646001777716Krajowe Centrum ds. AIDS2016Not specifiedNot specifiedNot specified
94UkraineGovernmentGlaxoSmithKlineAbacavir+Lamivudine - FDC600mg+300mg tab0.97971719303029.395731168434.092015Not specifiedNot specifiedNot specified
95Republic of KazakhstanGovernmentViiV HealthcareKivexaAbacavir+Lamivudine - FDC600mg+300mg tab0.377730474003011.331015801150901.382015Not specifiedNot specifiedNot specified
96Republic of PolandGovernmentGlaxoSmithKlineKivexaAbacavir+Lamivudine - FDC600mg+300mg tab12.882300030386.4610038646Krajowe Centrum ds. AIDS2016YesYesNot specified
97Republic of LatviaGovernmentViiv Healthcare UK LimitedKivexaAbacavir+Lamivudine - FDC600mg+300mg tab13.18819776030395.6465922608059National Health Service (NHC)2016Not specifiedNot specifiedNot specified
98Republic of MoldovaGlobal FundCipla LtdAbacavir+Lamivudine - FDC60mg+30mg tab0.1221060607.23512527.22015Not specifiedYesNot specified
99Republic of MoldovaGlobal FundAurobindo Pharma Ltd.Abacavir+Lamivudine - FDC60mg+30mg tab0.1244460607.27415335.2IDA FoundationNot specifiedNot specifiedNot specified
100Republic of KazakhstanGovernmentAurobindo Pharma Ltd.Abacavir+LamivudimAbacavir+Lamivudine - FDC600mg+300mg tab0.0630301.811.82016YesNot specifiedYes
101UkraineGlobal FundGlaxoSmithKlineAbacavir+Lamivudine - FDC600mg+300mg tab1.02303030.6130.62015Not specifiedNot specifiedNot specified
102Republic of LithuaniaInsurance FundViiv Healthcare UK LimitedKivexaAbacavir+Lamivudine - FDC600mg+300mg tab7.51933030225.581225.582016YesYesNot specified
103GeorgiaGlobal FundMYLAN LABORATORIES LTDAbacavir+Lamivudine - FDC600mg+300mg tab0.4163263703012.4987910978.71partnership for supply. chain management (PFSCM)2016YesYesNot specified
104Republic of PolandGovernmentGlaxoSmithKlineTrizivirAbacavir+Lamivudine+Zidovudine - FDC300mg+150mg+300mg tab9.3723180060562.343016870.2Krajowe Centrum ds. AIDS2016YesYesNot specified
105Republic of PolandGovernmentViiV HealthcareTrizivirAbacavir+Lamivudine+Zidovudine - FDC300mg+150mg+300mg tab9.791790060587.5158812.52015Not specifiedNot specifiedNot specified
106Republic of KazakhstanGovernmentViiV HealthcareAbacavir+Lamivudine+Zidovudine - FDC300mg+150mg+300mg tab0.10783877200606.4764620418091.412015Not specifiedNot specifiedNot specified
107Republic of KazakhstanGovernmentViiV HealthcareAbacavir+Lamivudine+Zidovudine - FDC300mg+150mg+300mg tab0.10783600606.4760388.22015Not specifiedNot specifiedNot specified
108Republic of KazakhstanGovernmentGlaxoSmithKlineTrizivirAbacavir+Lamivudine+Zidovudine - FDC300mg+150mg+300mg tab0.063360603.813.82016Not specifiedYesNot specified
109Republic of MoldovaGlobal FundEmcure Pharmaceuticals Ltd.Atazanavir (ATV)300mg caps0.698350103020.951673498.65IDA Foundation2015Not specifiedYesNot specified
110Republic of PolandGovernmentBristol-Myers SquibbReyatazAtazanavir (ATV)200mg caps7.513800604502301035002015Not specifiedNot specifiedNot specified
111Russian FederationGovernmentBristol-Myers SquibbReyatazAtazanavir (ATV)300mg caps3.60311103030108.093701400041.092015Not specifiedNot specifiedNot specified
112Republic of PolandGovernmentBristol-Myers SquibbReyatazAtazanavir (ATV)300mg caps15.41672700030462.59004162502015Not specifiedNot specifiedNot specified
113Russian FederationGovernmentBristol-Myers SquibbReyatazAtazanavir (ATV)200mg caps2.137103896060128.22173162220257.52016YesYesNot specified
114Republic of PolandGovernmentBristol-Myers SquibbReyatazAtazanavir (ATV)200mg caps6.6152300060396.915019845.5Krajowe Centrum ds. AIDS2016Not specifiedNot specifiedNot specified
115Russian FederationGovernmentBristol-Myers SquibbReyatazAtazanavir (ATV)200mg caps2.13769264060128.22115441480171.622016YesYesNot specified
116Republic of LatviaGovernmentBristol-Myers SquibbReyatazAtazanavir (ATV)300mg caps13.09573030392.871392.872015Not specifiedNot specifiedNot specified
117Republic of PolandGovernmentBristol-Myers SquibbReyatazAtazanavir (ATV)300mg caps14.01837200030420.5524001009320Krajowe Centrum ds. AIDS2016YesYesNot specified
118Republic of PolandGovernmentBristol-Myers SquibbReyatazAtazanavir (ATV)300mg caps15.4167300030462.5100462502015Not specifiedNot specifiedNot specified
119GeorgiaGlobal FundEmcure Pharmaceuticals Ltd.Atazanavir (ATV)300mg caps0.6486003018162029160partnership for supply. chain management (PFSCM)2015NoYesNot specified
120Republic of PolandGovernmentBristol-Myers SquibbReyatazAtazanavir (ATV)300mg caps15.416716200030462.5540024975002015Not specifiedNot specifiedNot specified
121Russian FederationGovernmentBristol-Myers SquibbReyatazAtazanavir (ATV)150mg caps1.7975553782060107.859229799542312015Not specifiedNot specifiedNot specified
122Republic of BelarusGlobal FundEmcure Pharmaceuticals Ltd.Atazanavir (ATV)300mg caps0.56671563030175218857UNDP/UNICEF2016NoNoNot specified
123Republic of PolandGovernmentBristol-Myers SquibbReyatazAtazanavir (ATV)300mg caps11.62971800030348.89600209334Krajowe Centrum ds. AIDS2016Not specifiedNot specifiedNot specified
124Republic of LatviaGovernmentBristol-Myers SquibbReyatazAtazanavir (ATV)300mg caps14.83376726030445.012242997712.44National Health Service (NHC)2016Not specifiedNot specifiedNot specified
125Russian FederationGovernmentBristol-Myers SquibbReyatazAtazanavir (ATV)200mg caps1.6511500609685258184002016YesYesNot specified
126Republic of MoldovaGlobal FundEmcure Pharmaceuticals Ltd.Atazanavir (ATV)300mg caps0.698350103020.951673498.65IDA Foundation2016Not specifiedNot specifiedNot specified
127Russian FederationGovernmentBristol-Myers SquibbReyatazAtazanavir (ATV)150mg caps1.6341100609656855457602016YesYesNot specified
128Republic of PolandGovernmentBristol-Myers SquibbReyatazAtazanavir (ATV)150mg caps6.8198660060409.1911045010.9Krajowe Centrum ds. AIDS2016YesYesNot specified
129Russian FederationGovernmentBristol-Myers SquibbReyatazAtazanavir (ATV)200mg caps2.37471000794060142.48166799237655222015Not specifiedNot specifiedNot specified
130Republic of BelarusGlobal FundEmcure Pharmaceuticals Ltd.Atazanavir (ATV)300mg caps0.5667432030171442448IDA Foundation20152015-12-222016-04-14NoNoNot specified
131Republic of PolandGovernmentBristol-Myers SquibbEvotazAtazanavir+Cobicistat300mg+150mg tab14.77636900030443.2923001019567Krajowe Centrum ds. AIDS2016YesYesNot specified
132Republic of PolandGovernmentBristol-Myers SquibbEvotazAtazanavir+Cobicistat300mg+150mg tab14.33390030429.993012899.7Krajowe Centrum ds. AIDS2016Not specifiedNot specifiedNot specified
133Republic of PolandGovernmentBristol-Myers SquibbEvotazAtazanavir+Cobicistat300mg+150mg tab16.253600030487.512005850002015Not specifiedNot specifiedNot specified
134Republic of ArmeniaGlobal FundEmcure Pharmaceuticals Ltd.Atazanavir+Ritonavir - FDC300mg+100mg tab0.5543203016.51442376partnership for supply. chain management (PFSCM)2016NoYesNot specified
135Republic of ArmeniaGlobal FundEmcure Pharmaceuticals Ltd.Atazanavir+Ritonavir - FDC300mg+100mg tab0.5538703016.51292128.5partnership for supply. chain management (PFSCM)2016NoYesNot specified
136GeorgiaGlobal FundMYLAN LABORATORIES LTDAtazanavir+Ritonavir - FDC300mg+100mg tab0.55588003016.5196032340partnership for supply. chain management (PFSCM)2016YesYesNot specified
137Republic of TajikistanGlobal FundEmcure Pharmaceuticals Ltd.Atazanavir+Ritonavir - FDC300mg+100mg tab0.55201603016.567211088UNDP/UNICEFNot specifiedNot specifiedNot specified
138Republiс of AzerbaijanGovernmentCipla LtdAtazanavir+Ritonavir - FDC300mg+100mg tab2.236750403067.116811272.82015YesYesNot specified
139Republic of LithuaniaInsurance FundJanssen-Cilag Internarional NVPrezistaDarunavir (TCM)400mg tab7.55336060453.21453.22016YesYesYes
140Republic of BelarusGovernmentHetero Labs + ФарматехDarunavir (TCM)600mg tab6.98133168060418.88528221168.64Фарматех ЗАО2015Not specifiedNot specifiedNot specified
141Russian FederationGovernmentHetero labs Ltd.DarunavirDarunavir (TCM)600mg tab5.8519099806035131833111733832016YesYesNot specified
142Republic of PolandGovernmentJanssenPrezistaDarunavir (TCM)800mg tab13.7887650030413.64255010547822015Not specifiedNot specifiedNot specified
143Russian FederationGovernmentPharmasyntezKemeruvirDarunavir (TCM)600mg tab6.8323215754060409.9435959147410322015Not specifiedNot specifiedNot specified
144Republic of LatviaGovernmentJanssenPrezistaDarunavir (TCM)400mg tab7.81176060468.71468.72015Not specifiedNot specifiedNot specified
145Republic of PolandGovernmentJanssenPrezistaDarunavir (TCM)150mg tab2.63822400240633.16106331.6Krajowe Centrum ds. AIDS2016Not specifiedYesNot specified
146Republic of LithuaniaInsurance FundJanssen-Cilag Internarional NVPrezistaDarunavir (TCM)600mg tab11.32786060679.671679.672016YesYesYes
147GeorgiaGlobal FundHetero labs Ltd.PrezistaDarunavir (TCM)600mg tab1.166738580607064345010partnership for supply. chain management (PFSCM)2016YesYesYes
148Republic of PolandGovernmentJanssenPrezistaDarunavir (TCM)600mg tab11.0258700060661.514509591752015Not specifiedNot specifiedNot specified
149Russian FederationGovernmentHetero labs Ltd.DarunavirDarunavir (TCM)400mg tab3.8622542060231.63757870121.192016YesYesNot specified
150Russian FederationGovernmentJanssenPrezistaDarunavir (TCM)600mg tab7.059544448060423.5774083137806.52015Not specifiedNot specifiedNot specified
151Republic of LatviaGovernmentJanssen-Cilag Internarional NVPrezistaDarunavir (TCM)600mg tab11.6655468060699.937854594.54National Health Service (NHC)2016Not specifiedNot specifiedYes
152UkrainePEPFARJanssenPrezistaDarunavir (TCM)400mg tab5.040790060302.44154536.62016Not specifiedNot specifiedNot specified
153Republic of PolandGovernmentJanssenPrezistaDarunavir (TCM)800mg tab12.16136600030364.842200802648Krajowe Centrum ds. AIDS2016Not specifiedNot specifiedNot specified
154Republic of KazakhstanGovernmentJanssenPrezistaDarunavir (TCM)600mg tab0.1160606.616.62016YesNot specifiedNot specified
155UkraineGovernmentJanssenDarunavir (TCM)600mg tab8.5543140605137193688472015Not specifiedNot specifiedNot specified
156Republic of MoldovaGlobal FundHetero labs Ltd.Darunavir (TCM)600mg tab1.82021728060109.2128831452.48IDA Foundation2016Not specifiedNot specifiedNot specified
157Russian FederationGovernmentJanssenPrezistaDarunavir (TCM)400mg tab5.043318060302.585316036.742015Not specifiedNot specifiedNot specified
158UkraineGovernmentJanssenPrezistaDarunavir (TCM)400mg tab5.3692222060322.153711919.552016YesYesNot specified
159Republic of PolandGovernmentJanssenPrezistaDarunavir (TCM)800mg tab13.7881365030413.64455188206.22015Not specifiedNot specifiedNot specified
160Republic of MoldovaGlobal FundHetero labs Ltd.Darunavir (TCM)600mg tab1.8202726060109.2112113214.412015Not specifiedNot specifiedNot specified
161Republic of TajikistanGlobal FundJanssenDarunavir (TCM)600mg tab1.27528806076.5483672UNDP/UNICEFNot specifiedNot specifiedNot specified
162Republic of MoldovaGlobal FundHetero labs Ltd.Darunavir (TCM)600mg tab1.8202138060109.21232511.832015Not specifiedNot specifiedNot specified
163Republic of ArmeniaGlobal FundHetero labs Ltd.Darunavir (TCM)600mg tab1.166736060706420partnership for supply. chain management (PFSCM)2016NoNoNot specified
164Russian FederationGovernmentPharmasyntezKemeruvirDarunavir (TCM)600mg tab3.8833810060232.8563513118282016YesYesNot specified
165Republic of ArmeniaGlobal FundJanssenPrezistaDarunavir (TCM)600mg tab11.63006069653480partnership for supply. chain management (PFSCM)2016YesNoNot specified
166Russian FederationGovernmentJanssenPrezistaDarunavir (TCM)800mg tab10.27191091030308.163697196250462015Not specifiedNot specifiedNot specified
167Republic of ArmeniaGlobal FundJanssenDarunavir (TCM)600mg tab11.61806069632088VPP, through Partnership for Supply Chain Management (PFSCM)20152015-03-112015-10-14Not specifiedNot specifiedNot specified
168Republic of LatviaGovernmentJanssenPrezistaDarunavir (TCM)600mg tab10.35536060621.321621.322015Not specifiedNot specifiedNot specified
169Republic of PolandGovernmentJanssenPrezistaDarunavir (TCM)800mg tab12.537326700030376.1289003347468Krajowe Centrum ds. AIDS2016Not specifiedYesNot specified
170Republic of LithuaniaInsurance FundJanssen-Cilag Internarional NVPrezistaDarunavir (TCM)800mg tab15.10673030453.21453.22016YesYesYes
171Republic of PolandGovernmentJanssenPrezistaDarunavir (TCM)800mg tab14.98546500030449.551550069680252015Not specifiedNot specifiedNot specified
172Russian FederationGovernmentPharmasyntezKemeruvirDarunavir (TCM)600mg tab5.8519920060351332011653202016YesYesNot specified
173Republic of MoldovaGlobal FundHetero labs Ltd.Darunavir (TCM)600mg tab1.8202864060109.2114415726.24IDA Foundation2015Not specifiedYesNot specified
174Russian FederationGovernmentHetero labs Ltd.DarunavirDarunavir (TCM)600mg tab6.55033054060393.02509200047.192015Not specifiedNot specifiedNot specified
175Republic of LatviaGovernmentJanssen-Cilag Internarional NVPrezistaDarunavir (TCM)400mg tab8.82553804060529.53634335722.03National Health Service (NHC)2016Not specifiedNot specifiedYes
176UkrainePEPFARJanssenPrezistaDarunavir (TCM)600mg tab7.5612052060453.66342155151.722016YesYesNot specified
177Republic of PolandGovernmentJanssenPrezistaDarunavir (TCM)600mg tab9.72431800060583.46300175038Krajowe Centrum ds. AIDS2016Not specifiedNot specifiedNot specified
178UkraineGovernmentJanssenDarunavir (TCM)400mg tab5.722206034237126542015Not specifiedNot specifiedNot specified
179Republic of PolandGovernmentJanssenPrezistaDarunavir (TCM)150mg tab2.75631920240661.5852922015Not specifiedNot specifiedNot specified
180Russian FederationGovernmentPharmasyntezKemeruvirDarunavir (TCM)600mg tab5.8224186060349.240311407625.252016YesYesNot specified
181Russian FederationGovernmentPharmasyntezKemeruvirDarunavir (TCM)400mg tab4.604278438060276.25130733611416.252015Not specifiedNot specifiedNot specified
182Republic of KazakhstanGovernmentJanssenPrezistaDarunavir (TCM)400mg tab0.073360604.414.42016Not specifiedNot specifiedNot specified
183Republiс of AzerbaijanGovernmentJanssenPrezistaDarunavir (TCM)600mg tab20.566211520601233.97192236922.232015YesYesNot specified
184GeorgiaGlobal FundJanssenDarunavir (TCM)600mg tab11.61368060696228158688partnership for supply. chain management (PFSCM)2015NoYesNot specified
185UkraineGovernmentJanssenPrezistaDarunavir (TCM)600mg tab8.05374314060483.22719347435.192016YesYesNot specified
186Russian FederationGovernmentPharmasyntezKemeruvirDarunavir (TCM)800mg tab8.63771587030259.13529137079.772015Not specifiedNot specifiedNot specified
187Republic of BelarusGovernmentHetero Labs + ФарматехDarunavirDarunavir (TCM)600mg tab7.63168060456528240768Republican unitary enterprise "BELPHARMATSIYA"20152016-02-042016-03-13YesYesNot specified
188Republic of PolandGovernmentJanssenPrezistaDarunavir (TCM)600mg tab10.02274200060601.36700420952Krajowe Centrum ds. AIDS2016Not specifiedYesNot specified
189Republic of PolandGovernmentJanssenRezolstaDarunavir+Cobicistat800mg+150mg tab12.88136000030386.442000772880Krajowe Centrum ds. AIDS2016YesYesNot specified
190Republic of LatviaGovernmentJanssen-Cilag Internarional NVRezolstaDarunavir+Cobicistat800mg+150mg tab17.65133372030529.541124595202.94National Health Service (NHC)2016Not specifiedNot specifiedNot specified
191Republic of LithuaniaGovernmentJanssen-Cilag Internarional NVRezolstaDarunavir+Cobicistat800mg+150mg tab17.29873030518.961518.962015Not specifiedNot specifiedNot specified
192Republic of PolandGovernmentBristol-Myers SquibbRezolstaDarunavir+Cobicistat800mg+150mg tab14.1666600030424.9822009349562015Not specifiedNot specifiedNot specified
193Republic of PolandGovernmentJanssenRezolstaDarunavir+Cobicistat800mg+150mg tab12.881311100030386.4437001429828Krajowe Centrum ds. AIDS2016Not specifiedYesNot specified
194Republic of PolandGovernmentJanssenRezolstaDarunavir+Cobicistat800mg+150mg tab12.467323550030374.0278502936057Krajowe Centrum ds. AIDS2016Not specifiedNot specifiedNot specified
195Republic of LatviaGovernmentJanssen-Cilag Internarional NVRezolstaDarunavir+Cobicistat800mg+150mg tab15.62373030468.711468.712015Not specifiedNot specifiedNot specified
196Republic of LithuaniaInsurance FundJanssen-Cilag Internarional NVRezolstaDarunavir+Cobicistat800mg+150mg tab18.1633030544.891544.892016YesYesNot specified
197Republic of PolandGovernmentBristol-Myers SquibbRezolstaDarunavir+Cobicistat800mg+150mg tab14.166300030424.98100424982015Not specifiedNot specifiedNot specified
198Russian FederationGovernmentBristol-Myers SquibbVidexDidanosine250mg caps0.97934503029.1311590646.52016Not specifiedYesNot specified
199Republic of ArmeniaGlobal FundAurobindo Pharma Ltd.Didanosine250mg caps0.4480301216192VPP, through Partnership for Supply Chain Management (PFSCM)20152015-03-112015-10-14Not specifiedNot specifiedNot specified
200Russian FederationGovernmentAurobindo Pharma Ltd.DidanosineDidanosine400mg caps1.39217098503041.76569952380111.252015Not specifiedNot specifiedNot specified
201GeorgiaGlobal FundAurobindo Pharma Ltd.Didanosine400mg caps0.666718003020601200partnership for supply. chain management (PFSCM)2015NoNot specifiedNot specified
202Russian FederationGovernmentAurobindo Pharma Ltd.DidanosineDidanosine250mg caps1.1285157603033.8417192581777.252015Not specifiedNot specifiedNot specified
203Russian FederationGovernmentBristol-Myers SquibbVidexDidanosine125mg caps0.9523379203028.57126436112.482015Not specifiedNot specifiedNot specified
204Republiс of AzerbaijanGovernmentAurobindo Pharma Ltd.DidanosineDidanosine250mg caps0.9503174903028.5158316621.332015YesYesNot specified
205Republic of LatviaGovernmentBristol-Myers SquibbVidexDidanosine400mg caps5.61473030168.441168.442015Not specifiedNot specifiedNot specified
206Russian FederationGovernmentAurobindo Pharma Ltd.DidanosineDidanosine400mg caps1.26241803036208067490162016YesYesNot specified
207Republic of LatviaGovernmentBristol-Myers SquibbVidexDidanosine400mg caps6.496-30194.88--National Health Service (NHC)2016Not specifiedNot specifiedNot specified
208Republic of ArmeniaGlobal FundAurobindo Pharma Ltd.Didanosine400mg caps0.733318903022631386VPP, through Partnership for Supply Chain Management (PFSCM)20152015-03-112015-10-14Not specifiedNot specifiedNot specified
209Russian FederationGovernmentBristol-Myers SquibbVidexDidanosine125mg caps0.8410803025.236907.22016YesYesNot specified
210Russian FederationGovernmentBristol-Myers SquibbVidexDidanosine400mg caps1.40113008303042.03433611822462.882015Not specifiedNot specifiedNot specified
211Republic of KazakhstanGovernmentRanbaxy Laboratories LimitedDidanosine100mg tab0.02452826000601.4747100692372015Not specifiedNot specifiedNot specified
212Russian FederationGovernmentBristol-Myers SquibbVidexDidanosine250mg caps1.12874755003033.86158505366812015Not specifiedNot specifiedNot specified
213Russian FederationGovernmentBristol-Myers SquibbVidexDidanosine2g powder1743721174372743242015Not specifiedNot specifiedNot specified
214Russian FederationGovernmentGlaxoSmithKlineTivicayDolutegravir (as sodium salt)50mg tab7.531278030225.942696233.42016YesYesNot specified
215Republic of PolandGovernmentGlaxoSmithKlineTivicayDolutegravir (as sodium salt)50mg tab15.91312300030477.3941001957299Krajowe Centrum ds. AIDS2016YesYesNot specified
216Republic of BelarusGlobal FundGlaxo Operations UK LimitedTivicayDolutegravir (as sodium salt)50mg tab6.3493615030190.4820539048.4UNDP/UNICEF2016YesNoYes
217Republic of LatviaGovernmentViiv Healthcare UK LimitedTivicayDolutegravir (as sodium salt)50mg tab20.72633030621.791621.792015Not specifiedNot specifiedNot specified
218Republic of PolandGovernmentViiv Healthcare UK LimitedTivicayDolutegravir (as sodium salt)50mg tab17.515000305255002625002015Not specifiedNot specifiedNot specified
219Republic of BelarusGlobal FundViiV HealthcareDolutegravir (as sodium salt)50mg tab5.433330003016310016300IDA Foundation20152015-12-072016-05-28Not specifiedNot specifiedNot specified
220UkraineGovernmentAurobindo Pharma Ltd.DolutegravirDolutegravir (as sodium salt)50mg tab0.190324780305.718264716.462016YesYesYes
221Republic of PolandGovernmentGlaxoSmithKlineTivicayDolutegravir (as sodium salt)50mg tab15.9137500030477.3925001193475Krajowe Centrum ds. AIDS2016YesYesNot specified
222UkraineGovernmentViiV HealthcareDolutegravir (as sodium salt)50mg tab6.83572478030205.07826169387.812015Not specifiedNot specifiedNot specified
223Republic of LithuaniaInsurance FundViiv Healthcare UK LimitedTivicayDolutegravir (as sodium salt)50mg tab25.90233030777.071777.072016YesYesNot specified
224Republic of PolandGovernmentViiv Healthcare UK LimitedTivicayDolutegravir (as sodium salt)50mg tab17.5318003052510605565002015Not specifiedNot specifiedNot specified
225GeorgiaGlobal FundAurobindo Pharma Ltd.Dolutegravir (as sodium salt)50mg tab0.122310170303.673391244.13partnership for supply. chain management (PFSCM)2016YesYesNot specified
226Republic of LithuaniaGovernmentViiv Healthcare UK LimitedTivicayDolutegravir (as sodium salt)50mg tab24.6693030740.071740.072015Not specifiedNot specifiedNot specified
227Republic of BelarusGlobal FundViiV HealthcareDolutegravir (as sodium salt)50mg tab5.433330003016310016300IDA Foundation20152015-12-072016-04-19Not specifiedNot specifiedNot specified
228Republic of PolandGovernmentViiv Healthcare UK LimitedTivicayDolutegravir (as sodium salt)50mg tab17.5570003052519009975002015Not specifiedNot specifiedNot specified
229Republic of PolandGovernmentViiv Healthcare UK LimitedTivicayDolutegravir (as sodium salt)50mg tab0.017760000300.53200010602015Not specifiedNot specifiedNot specified
230GeorgiaGlobal FundAurobindo Pharma Ltd.DolutegravirDolutegravir (as sodium salt)50mg tab0.122318630303.676212279.07partnership for supply. chain management (PFSCM)2016YesYesYes
231UkrainePEPFARAurobindo Pharma Ltd.DolutegravirDolutegravir (as sodium salt)50mg tab0.166734090203051136345681702016YesYesYes
232Republic of LatviaGovernmentViiv Healthcare UK LimitedTivicayDolutegravir (as sodium salt)50mg tab23.33835631030700.1518771314181.5National Health Service (NHC)2016Not specifiedNot specifiedNot specified
233Republic of PolandGovernmentGlaxoSmithKlineTivicayDolutegravir (as sodium salt)50mg tab15.986716800030479.656002685760Krajowe Centrum ds. AIDS2016Not specifiedNot specifiedNot specified
234Republic of LatviaGovernmentViiv Healthcare UK LimitedTRIUMEQDolutegravir+Abacavir/Lamivudine50mg+600mg+300mg tab36.44327630301093.299211006920.06National Health Service (NHC)2016Not specifiedNot specifiedNot specified
235Republic of PolandGovernmentGlaxoSmithKlineTriumeqDolutegravir+Abacavir/Lamivudine50mg+600mg+300mg tab23.02112600030690.6342002900646Krajowe Centrum ds. AIDS2016Not specifiedYesNot specified
236Republic of LatviaGovernmentViiv Healthcare UK LimitedTRIUMEQDolutegravir+Abacavir/Lamivudine50mg+600mg+300mg tab32.4843030974.521974.522015Not specifiedNot specifiedNot specified
237Republic of PolandGovernmentViiv Healthcare UK LimitedTRIUMEQDolutegravir+Abacavir/Lamivudine50mg+600mg+300mg tab26.112000307834003132002015Not specifiedNot specifiedNot specified
238Republic of PolandGovernmentGlaxoSmithKlineTriumeqDolutegravir+Abacavir/Lamivudine50mg+600mg+300mg tab23.73312600030711.9942002990358Krajowe Centrum ds. AIDS2016YesYesNot specified
239Republic of LithuaniaInsurance FundViiv Healthcare UK LimitedTRIUMEQDolutegravir+Abacavir/Lamivudine50mg+600mg+300mg tab33.421330301002.6411002.642016YesYesNot specified
240Republic of PolandGovernmentViiv Healthcare UK LimitedTRIUMEQDolutegravir+Abacavir/Lamivudine50mg+600mg+300mg tab26.14500030783150011745002015Not specifiedNot specifiedNot specified
241Republic of PolandGovernmentViiv Healthcare UK LimitedTRIUMEQDolutegravir+Abacavir/Lamivudine50mg+600mg+300mg tab26.113500307834503523502015Not specifiedNot specifiedNot specified
242Republic of MoldovaGovernmentRanbaxy Laboratories LimitedAviranzEfavirenz200mg tab0.0811250907.2125900Dita Estfarm SRL2015Not specifiedNot specifiedYes
243Russian FederationGovernmentMakizpharmaEfavirenzEfavirenz600mg tab0.3812000003011.4400004560002016YesYesNot specified
244Republic of PolandGovernmentMerck Sharp & DohmeStocrinEfavirenz600mg tab5.0387630030151.1621031743.6Krajowe Centrum ds. AIDS2016YesYesNot specified
245GeorgiaNCDC GeorgiaArcolab LTDSustivaEfavirenz600mg tab0.0933742500302.82475069300partnership for supply. chain management (PFSCM)2016YesYesYes
246Republic of PolandGovernmentMerck Sharp & DohmeStocrinEfavirenz50mg caps0.72476003021.7420434.8Krajowe Centrum ds. AIDS2016YesYesNot specified
247Russian FederationGovernmentMerck Sharp & DohmeStocrinEfavirenz200mg tab0.22291726209020.06191838475.082015Not specifiedNot specifiedNot specified
248Republic of PolandGovernmentMerck Sharp & DohmeStocrinEfavirenz200mg tab2.95221080090265.712031884Krajowe Centrum ds. AIDS2016Not specifiedYesNot specified
249UkraineGovernmentStrides Arcolab LimitedEfavirenz600mg tab0.11072127180303.3270906235407.922015Not specifiedNot specifiedNot specified
250Republic of MoldovaGlobal FundHetero labs Ltd.Efavirenz600mg tab0.14430000304.3210004320IDA FoundationNot specifiedNot specifiedNot specified
251Republic of KazakhstanGovernmentRanbaxy Laboratories LimitedEfavirenz600mg tab0.08423741100302.527913701994252.382015Not specifiedNot specifiedNot specified
252Republic of PolandGovernmentMerck Sharp & DohmeStocrinEfavirenz600mg tab4.88532610030146.56870127507.2Krajowe Centrum ds. AIDS2016YesYesNot specified
253Republiс of AzerbaijanGovernmentStrides Arcolab LimitedEfavirenz200mg tab0.2588190809023.292124937.482015YesYesNot specified
254Republic of MoldovaGlobal FundMYLAN LABORATORIES LTDEfavirenz600mg tab0.14415000304.325002160IDA Foundation2015Not specifiedYesNot specified
255Republic of TajikistanGlobal FundStrides Arcolab LimitedEfavirenz600mg tab0.1097180000303.29600019740UNDP/UNICEF2016Not specifiedNot specifiedNot specified
256Russian FederationGovernmentPharmasyntezRegastEfavirenz100mg tab0.075227370302.25757917052.752015Not specifiedNot specifiedNot specified
257Republic of LithuaniaGovernmentGreat BritainStocrinEfavirenz600mg tab2.4883303074.65174.65Merck Sharp & Dohme Ltd2015Not specifiedYesNot specified
258UkraineGlobal FundHetero labs Ltd.Efavirenz600mg tab0.102330303.0713.072015Not specifiedNot specifiedNot specified
259Republic of LatviaGovernmentMerck Sharp & DohmeStocrinEfavirenz600mg tab1.388303041.64141.642015Not specifiedNot specifiedNot specified
260Republic of KazakhstanGovernmentZhangjiagang Huachang Pharmaceutical Industry Limited Company, ChinaEfavirenz200mg tab0.0162624400901.442916041990.42015Not specifiedNot specifiedNot specified
261GeorgiaGlobal FundStrides Arcolab LimitedEfavirenz600mg tab0.1063867960303.192893292293.08partnership for supply. chain management (PFSCM)2015NoNot specifiedNot specified
262Republic of ArmeniaGlobal FundMYLAN LABORATORIES LTDEfavirenz600mg tab0.116752650303.517556142.5partnership for supply. chain management (PFSCM)2016NoYesNot specified
263Republic of MoldovaGlobal FundAurobindo Pharma Ltd.Efavirenz50mg caps0.15372130304.6171327.31IDA Foundation2015Not specifiedYesNot specified
264Kyrgyz RepublicGlobal FundStrides Arcolab LimitedEfavirenz600mg tab0.1167-303.5--UNDP/UNICEF20152014-12-312015-12-30Not specifiedNot specifiedNot specified
265Republic of LithuaniaInsurance FundMerck Sharp & DohmeStocrinEfavirenz600mg tab2.6127303078.38178.382016YesYesNot specified
266GeorgiaGlobal FundArcolab LTDSustivaEfavirenz200mg tab0.314230309.31411311.3partnership for supply. chain management (PFSCM)2016YesYesYes
267Republic of MoldovaGovernmentHetero labs Ltd.EstivaEfavirenz600mg tab0.250366420307.51221416627.14Sanfarm-Prim SA2015Not specifiedNot specifiedNot specified
268Republic of ArmeniaGlobal FundStrides ShasunEfavirenz200mg tab0.10333060909.334316.2partnership for supply. chain management (PFSCM)2016NoYesNot specified
269Republic of TajikistanGlobal FundStrides Arcolab LimitedEfavirenz200mg tab0.103390909.319.32015Not specifiedNot specifiedNot specified
270Republic of UzbekistanGlobal FundStrides Arcolab LimitedEfavirenz200mg tab0.103390909.319.32015Not specifiedNot specifiedNot specified
271Republic of UzbekistanGlobal FundStrides Arcolab LimitedEfavirenzEfavirenz600mg tab0.056260603.3713.372016NoYesYes
272Russian FederationGovernmentPharmasyntezRegastEfavirenz600mg tab0.383321732003011.5724408330602016YesYesNot specified
273UkrainePEPFARHetero labs Ltd.EfavirenzEfavirenz600mg tab0.08832063640302.6568788182288.22016YesYesYes
274Republic of BelarusGovernmentHetero Labs + ФарматехEfavirenz600mg tab0.76671276500302342550978650Republican unitary enterprise "BELPHARMATSIYA"2016YesYesNot specified
275Russian FederationGovernmentPharmasyntezRegastEfavirenz600mg tab0.4353145377003013.064845906328745.52015Not specifiedNot specifiedNot specified
276Republic of PolandGovernmentMerck Sharp & DohmeStocrinEfavirenz200mg tab3.2467450090292.250146102015Not specifiedNot specifiedNot specified
277Russian FederationGovernmentMerck Sharp & DohmeStocrinEfavirenz600mg tab0.2422123790307.2670793513957.192015Not specifiedNot specifiedNot specified
278Republic of BelarusGovernmentHetero Labs + ФарматехEfavirenz600mg tab0.705712765003021.1742550900783.5Фарматех ЗАО2015Not specifiedNot specifiedNot specified
279UkraineGovernmentStrides Arcolab LimitedEfavirenzEfavirenz200mg tab0.1148925209010.33102810619.242016YesYesYes
280Kyrgyz RepublicGlobal FundStrides Arcolab LimitedEfavirenz200mg tab0.103389370909.39939234.9UNDP/UNICEF2016NoNoNot specified
281GeorgiaGlobal FundStrides Arcolab LimitedEfavirenz200mg tab0.103332400909.33603348partnership for supply. chain management (PFSCM)2015Not specifiedYesNot specified
282Republic of PolandGovernmentMerck Sharp & DohmeStocrinEfavirenz200mg tab2.9522450090265.75013285Krajowe Centrum ds. AIDS2016YesYesNot specified
283UkraineGlobal FundHetero labs Ltd.EstivaEfavirenz600mg tab0.10232847240303.0794908291367.562016YesYesNot specified
284Republic of EstoniaGovernmentMerck Sharp & DohmeStocrinEfavirenz600mg tab1.7573303052.72152.722015Not specifiedNot specifiedNot specified
285Russian FederationGovernmentPharmasyntezRegastEfavirenz600mg tab0.4353145377003013.064845906328745.52015Not specifiedNot specifiedNot specified
286Republic of MoldovaGlobal FundAurobindo Pharma Ltd.Efavirenz200mg tab0.1436136809012.921521963.84IDA Foundation2016Not specifiedNot specifiedNot specified
287Republic of KazakhstanGovernmentMerck Sharp & DohmeEfavirenz50mg tab0.6669750---460352015Not specifiedNot specifiedNot specified
288Republiс of AzerbaijanGovernmentStrides Arcolab LimitedEfavirenz50mg caps0.4467379503013.41265169512015YesYesNot specified
289UkraineGovernmentStrides Arcolab LimitedEfavirenz200mg tab0.1172924309010.55102710834.852015Not specifiedNot specifiedNot specified
290Republiс of AzerbaijanGovernmentStrides Arcolab LimitedEfavirenz600mg tab0.4596264003013.7720880287517.592015YesYesNot specified
291Republic of ArmeniaGlobal FundMYLAN LABORATORIES LTDEfavirenz600mg tab0.1248703038292487partnership for supply. chain management (PFSCM)2016NoYesNot specified
292Republic of TajikistanGlobal FundStrides Arcolab LimitedEfavirenz200mg tab0.103387480909.39729039.6UNDP/UNICEFNot specifiedNot specifiedNot specified
293Republic of LithuaniaGovernmentMerck Sharp & DohmeStocrinEfavirenz600mg tab2.351303070.53170.532015Not specifiedYesNot specified
294Republic of MoldovaGlobal FundStrides Arcolab LimitedEfavirenz200mg tab0.1436136809012.921521963.84IDA Foundation2015Not specifiedYesNot specified
295Republic of LithuaniaInsurance FundЛех АноStocrinEfavirenz600mg tab2.4687303074.06174.062016YesYesYes
296Republic of LatviaGovernmentMerck Sharp & DohmeStocrinEfavirenz600mg tab1.72232289003051.677630394242.09National Health Service (NHC)2016Not specifiedNot specifiedNot specified
297Republic of MoldovaGlobal FundMYLAN LABORATORIES LTDEfavirenz600mg tab0.14415000304.3250021602015Not specifiedNot specifiedNot specified
298Republic of ArmeniaGlobal FundMYLAN LABORATORIES LTDEfavirenz600mg tab0.116721000303.57002450VPP, through Partnership for Supply Chain Management (PFSCM)20152015-03-112015-10-14Not specifiedNot specifiedNot specified
299Kyrgyz RepublicGlobal FundStrides Arcolab LimitedEfavirenz200mg tab0.103389370909.39939234.9UNDP/UNICEF20152014-12-312015-12-30Not specifiedNot specifiedNot specified
300Republic of KazakhstanGovernmentZhangjiagang Huachang Pharmaceutical Industry Limited Company, ChinaEfavirenz600mg tab0.085379800302.5512660322832015Not specifiedNot specifiedNot specified
301Republic of TajikistanGlobal FundStrides Arcolab LimitedEfavirenz600mg tab0.112330303.3713.372015Not specifiedNot specifiedNot specified
302Republic of PolandGovernmentMerck Sharp & DohmeStocrinEfavirenz600mg tab5.853900030175.513002281502015Not specifiedNot specifiedNot specified
303Kyrgyz RepublicGlobal FundStrides Arcolab LimitedEfavirenz600mg tab0.3967105903011.93534200.7UNDP/UNICEF2016NoNoNot specified
304Republic of UzbekistanGlobal FundStrides Arcolab LimitedEfavirenzEfavirenz200mg tab0.103390909.319.32016NoYesYes
305Republic of ArmeniaGlobal FundStrides Arcolab LimitedEfavirenz200mg tab0.10332340909.326241.8VPP, through Partnership for Supply Chain Management (PFSCM)20152015-03-11Not specifiedNot specifiedNot specified
306Russian FederationGovernmentPharmasyntezRegastEfavirenz100mg tab0.064959040301.923196861378.562016YesYesNot specified
307Russian FederationGovernmentARS PharmEfavirenzEfavirenz200mg tab0.24972850307.4995711.552015Not specifiedNot specifiedNot specified
308UkraineGovernmentAurobindo Pharma Ltd.EfavirenzEfavirenz600mg tab0.1142127180303.4270906242498.522016YesYesYes
309Republic of UzbekistanGlobal FundStrides Arcolab LimitedEfavirenz600mg tab0.112330303.3713.372015Not specifiedNot specifiedNot specified
310Republic of PolandGovernmentGilead SciencesAtriplaEfavirenz+Emtricitabin+Tenofovir Disoproxil600mg+200mg+245mg tab26.436900030793.083002379242015Not specifiedNot specifiedNot specified
311Republic of PolandGovernmentGilead SciencesAtriplaEfavirenz+Emtricitabin+Tenofovir Disoproxil600mg+200mg+245mg tab26.436600030793.082001586162015Not specifiedNot specifiedNot specified
312Republic of MoldovaGlobal FundHetero labs Ltd.Efavirenz+Emtricitabine+Tenofovir - FDC600mg+200mg+300mg tab0.3531750503010.59583561792.65IDA FoundationNot specifiedNot specifiedNot specified
313Republic of BelarusGovernmentHetero Labs + ФарматехEfavirenz+Emtricitabine+Tenofovir - FDC600mg+200mg+300mg tab3.06679900030923300303600Republican unitary enterprise "BELPHARMATSIYA"2016YesNoNot specified
314Republic of BelarusGovernmentHetero Labs + ФарматехEfavirenz+Emtricitabine+Tenofovir - FDC600mg+200mg+300mg tab2.8033990003084.13300277530Фарматех ЗАО2015Not specifiedNot specifiedNot specified
315Kyrgyz RepublicGlobal FundHetero labs Ltd.Efavirenz+Emtricitabine+Tenofovir - FDC600mg+200mg+300mg tab0.3752322903011.25774387108.75UNDP/UNICEF2016NoNoNot specified
316Republic of ArmeniaGlobal FundMYLAN LABORATORIES LTDEfavirenz+Emtricitabine+Tenofovir - FDC600mg+200mg+300mg tab0.2663149670307.99498939862.11partnership for supply. chain management (PFSCM)2016NoYesNot specified
317Republic of TajikistanGlobal FundHetero labs Ltd.Efavirenz+Emtricitabine+Tenofovir - FDC600mg+200mg+300mg tab0.375303011.25111.252015Not specifiedNot specifiedNot specified
318Republic of MoldovaGlobal FundHetero labs Ltd.Efavirenz+Emtricitabine+Tenofovir - FDC600mg+200mg+300mg tab0.353875103010.59291730891.032015Not specifiedNot specifiedNot specified
319Republic of ArmeniaGlobal FundMYLAN LABORATORIES LTDEfavirenz+Emtricitabine+Tenofovir - FDC600mg+200mg+300mg tab0.324721960309.747327129.68VPP, through Partnership for Supply Chain Management (PFSCM)20152015-03-112015-10-14Not specifiedNot specifiedNot specified
320Republiс of AzerbaijanGovernmentGilead SciencesAtriplaEfavirenz+Emtricitabine+Tenofovir - FDC600mg+200mg+300mg tab1.3264089603039.7813632542280.942015YesYesNot specified
321Republic of UzbekistanGlobal FundMYLAN LABORATORIES LTDEfavirenz+Lamivudin+TDFEfavirenz+Emtricitabine+Tenofovir - FDC600mg+200mg+300mg tab0.274730308.2418.242016YesYesYes
322UkraineGovernmentHetero labs Ltd.TrastivaEfavirenz+Emtricitabine+Tenofovir - FDC600mg+200mg+300mg tab0.269350460308.071168294273.742016YesNot specifiedYes
323Republic of PolandGovernmentGilead SciencesAtriplaEfavirenz+Emtricitabine+Tenofovir - FDC600mg+200mg+300mg tab26.4369150030793.08305024188942015Not specifiedNot specifiedNot specified
324UkraineGovernmentMerck Sharp & DohmeEfavirenz+Emtricitabine+Tenofovir - FDC600mg+200mg+300mg tab1.16373504603034.9111682407818.622015Not specifiedNot specifiedNot specified
325Republic of MoldovaGovernmentRanbaxy Laboratories LimitedAviroday MEEfavirenz+Emtricitabine+Tenofovir - FDC600mg+200mg+300mg tab0.454302003013.514340193590Dita Estfarm SRL2015Not specifiedNot specifiedYes
326Republic of MoldovaGlobal FundHetero labs Ltd.Efavirenz+Emtricitabine+Tenofovir - FDC600mg+200mg+300mg tab0.353875403010.59291830901.62IDA Foundation2015Not specifiedYesNot specified
327UkraineGlobal FundMerck Sharp & DohmeEfavirenz+Emtricitabine+Tenofovir - FDC600mg+200mg+300mg tab13030301302015Not specifiedNot specifiedNot specified
328UkrainePEPFARHetero labs Ltd.TenofovirEfavirenz+Emtricitabine+Tenofovir - FDC600mg+200mg+300mg tab0.2186646020306.542215341448832.382016YesYesYes
329Republic of MoldovaGovernmentRanbaxy Laboratories LimitedEfavirenz+Emtricitabine+Tenofovir - FDC600mg+200mg+300mg tab0.5915197503017.7317325307172.25Dita Estfarm SRLNot specifiedNot specifiedNot specified
330Republic of ArmeniaGlobal FundStrides ShasunEfavirenz+Emtricitabine+Tenofovir - FDC600mg+200mg+300mg tab0.2867108540308.6361831114.8partnership for supply. chain management (PFSCM)2016NoYesNot specified
331Republic of TajikistanGlobal FundCipla LtdEfavirenz+Emtricitabine+Tenofovir - FDC600mg+200mg+300mg tab0.3167918000309.530600290700UNDP/UNICEF2016Not specifiedNot specifiedNot specified
332UkraineGlobal FundMerck Sharp & DohmeAtriplaEfavirenz+Emtricitabine+Tenofovir - FDC600mg+200mg+300mg tab1227259030307575322725902016YesYesYes
333Kyrgyz RepublicGlobal FundHetero labs Ltd.Efavirenz+Emtricitabine+Tenofovir - FDC600mg+200mg+300mg tab0.3752322903011.25774387108.75UNDP/UNICEF2015Not specifiedNot specifiedNot specified
334Republic of PolandGovernmentGilead SciencesStribildElvitegravis+Cobicistat+Emtricitabin+Tenofovir Disoproxil150mg+150mg+200mg+245mg tab26.52139600030795.6432002546048Krajowe Centrum ds. AIDS2016YesYesNot specified
335Republic of PolandGovernmentBristol-Myers SquibbStribildElvitegravis+Cobicistat+Emtricitabin+Tenofovir Disoproxil150mg+150mg+200mg+245mg tab29.1667330003087511009625002015Not specifiedNot specifiedNot specified
336Republic of PolandGovernmentGilead SciencesStribildElvitegravis+Cobicistat+Emtricitabin+Tenofovir Disoproxil150mg+150mg+200mg+245mg tab25.72573000030771.771000771770Krajowe Centrum ds. AIDS2016Not specifiedNot specifiedNot specified
337Republic of PolandGovernmentGilead SciencesGenvoyaElvitegravis+Cobicistat+Emtricitabin+Tenofovir Disoproxil150mg+150mg+200mg+245mg tab25.460722800030763.8276005805032Krajowe Centrum ds. AIDS2016Not specifiedNot specifiedNot specified
338Republic of PolandGovernmentGilead SciencesStribildElvitegravis+Cobicistat+Emtricitabin+Tenofovir Disoproxil150mg+150mg+200mg+245mg tab26.521312000030795.6440003182560Krajowe Centrum ds. AIDS2016YesYesNot specified
339Republic of PolandGovernmentGilead SciencesStribildElvitegravis+Cobicistat+Emtricitabin+Tenofovir Disoproxil150mg+150mg+200mg+245mg tab27.319360030819.5712098348.4Krajowe Centrum ds. AIDS2016YesYesNot specified
340Republic of PolandGovernmentBristol-Myers SquibbStribildElvitegravis+Cobicistat+Emtricitabin+Tenofovir Disoproxil150mg+150mg+200mg+245mg tab29.16675100030875170014875002015Not specifiedNot specifiedNot specified
341Republic of PolandGovernmentBristol-Myers SquibbStribildElvitegravis+Cobicistat+Emtricitabin+Tenofovir Disoproxil150mg+150mg+200mg+245mg tab29.16677500030875250021875002015Not specifiedNot specifiedNot specified
342Republic of PolandGovernmentGilead SciencesEmtrivaEmtricitabine200mg caps9.28180030278.46016704Krajowe Centrum ds. AIDS2016Not specifiedNot specifiedNot specified
343Republic of PolandGovernmentGilead SciencesEmtrivaEmtricitabine200mg caps7.972775030239.18255979.5Krajowe Centrum ds. AIDS2016Not specifiedYesNot specified
344Republic of PolandGovernmentGilead SciencesEmtrivaEmtricitabine200mg caps8.3293180030249.886014992.82015Not specifiedNot specifiedNot specified
345Russian FederationGovernmentPharmasyntezEmtritabEmtricitabine200mg tab0.1914160305.74722690.42016YesYesYes
346Republic of PolandGovernmentGilead SciencesEmtrivaEmtricitabine200mg caps8.3293210030249.887017491.62015Not specifiedNot specifiedNot specified
347Republic of PolandGovernmentGilead SciencesEvipleraEmtricitabine+Rilpivirine+Tenofovir200mg+25mg+245mg tab26.77333000030803.210008032002015Not specifiedNot specifiedNot specified
348Republic of PolandGovernmentGilead SciencesEvipleraEmtricitabine+Rilpivirine+Tenofovir200mg+300mg+25mg tab24.3457500030730.3525001825875Krajowe Centrum ds. AIDS2016YesYesNot specified
349Republic of PolandGovernmentGilead SciencesEvipleraEmtricitabine+Rilpivirine+Tenofovir200mg+300mg+25mg tab24.34513500030730.3545003286575Krajowe Centrum ds. AIDS2016Not specifiedYesNot specified
350Russian FederationGovernmentGilead SciencesEvipleraEmtricitabine+Rilpivirine+Tenofovir200mg+300mg+25mg tab29.51032094030885.31698617946.382015Not specifiedNot specifiedNot specified
351Republic of PolandGovernmentGilead SciencesEvipleraEmtricitabine+Rilpivirine+Tenofovir200mg+25mg+245mg tab26.77337350030803.2245019678402015Not specifiedNot specifiedNot specified
352Republic of PolandGovernmentGilead SciencesEvipleraEmtricitabine+Rilpivirine+Tenofovir200mg+25mg+245mg tab26.773320100030803.2670053814402015Not specifiedNot specifiedNot specified
353Republic of PolandGovernmentGilead SciencesEvipleraEmtricitabine+Rilpivirine+Tenofovir200mg+25mg+245mg tab23.614710200030708.4434002408696Krajowe Centrum ds. AIDS2016Not specifiedNot specifiedNot specified
354Republic of PolandGovernmentGilead SciencesAtriplaEmtricitabine+Rilpivirine+Tenofovir200mg+300mg+25mg tab24.03835100030721.1517001225955Krajowe Centrum ds. AIDS2016YesYesNot specified
355Republic of PolandGovernmentGilead SciencesOdefseyEmtricitabine+Rilpivirine+Tenofovir200mg+25mg+245mg tab23.386315900030701.5953003718427Krajowe Centrum ds. AIDS2016Not specifiedNot specifiedNot specified
356Republic of LatviaGovernmentGilead SciencesTruvadaEmtricitabine+Tenofovir - FDC200mg+245mg tab15.64273030469.281469.282015Not specifiedNot specifiedNot specified
357Republic of ArmeniaGlobal FundMYLAN LABORATORIES LTDEmtricitabine+Tenofovir - FDC200mg+300mg tab0.17920220305.376743619.38VPP, through Partnership for Supply Chain Management (PFSCM)20152016-03-112015-10-14Not specifiedNot specifiedNot specified
358Republic of MoldovaGlobal FundMYLAN LABORATORIES LTDEmtricitabine+Tenofovir - FDC200mg+300mg tab0.223333120306.711047396.82015Not specifiedNot specifiedNot specified
359Republic of MoldovaGlobal FundMYLAN LABORATORIES LTDEmtricitabine+Tenofovir - FDC200mg+300mg tab0.223333120306.711047396.8IDA Foundation2015Not specifiedYesNot specified
360Republic of PolandGovernmentGilead SciencesTruvadaEmtricitabine+Tenofovir - FDC200mg+245mg tab17.269318150030518.08605031343842015Not specifiedNot specifiedNot specified
361Republic of LatviaGovernmentGilead SciencesTruvadaEmtricitabine+Tenofovir - FDC200mg+245mg tab17.67276942030530.1823141226836.5National Health Service (NHC)2016Not specifiedNot specifiedNot specified
362Republic of TajikistanGlobal FundMYLAN LABORATORIES LTDEmtricitabine+Tenofovir - FDC200mg+300mg tab0.17952560305.3717529408.24UNDP/UNICEF2016Not specifiedNot specifiedNot specified
363Republic of KazakhstanGovernmentGilead SciencesEmtricitabine+Tenofovir - FDC200mg+300mg tab0.11877237800303.56241260858885.622015Not specifiedNot specifiedNot specified
364UkraineGlobal FundMacleods Pharmaceuticals LtdEmtricitabine+Tenofovir - FDC200mg+300mg tab0.178730305.3615.362015Not specifiedNot specifiedNot specified
365Republic of MoldovaGlobal FundHetero labs Ltd.Emtricitabine+Tenofovir - FDC200mg+300mg tab0.223366240306.7220814793.6IDA Foundation2016Not specifiedNot specifiedNot specified
366GeorgiaGlobal FundHetero labs Ltd.Emtricitabine+Tenofovir - FDC200mg+300mg tab0.1973824040305.9227468162610.56partnership for supply. chain management (PFSCM)2015Not specifiedNot specifiedNot specified
367Republic of BelarusGovernmentHetero Labs + ФарматехEmtricitabine+Tenofovir - FDC200mg+300mg tab1.28336352206077105878151992016Not specifiedYesNot specified
368Republic of ArmeniaGlobal FundMYLAN LABORATORIES LTDEmtricitabine+Tenofovir - FDC200mg+300mg tab0.17579320305.25264413881partnership for supply. chain management (PFSCM)2016NoYesNot specified
369Republic of BelarusGovernmentHetero Labs + ФарматехEmtricitabine+Tenofovir - FDC200mg+300mg tab2.34933176103070.4810587746171.75Фарматех ЗАО2015Not specifiedNot specifiedNot specified
370Kyrgyz RepublicGlobal FundMYLAN LABORATORIES LTDEmtricitabine+Tenofovir - FDC200mg+300mg tab0.2003-306.01--UNDP/UNICEF20152014-12-312015-12-30Not specifiedNot specifiedNot specified
371Republic of TajikistanGlobal FundHetero labs Ltd.Emtricitabine+Tenofovir - FDC200mg+300mg tab0.200330306.0116.012015Not specifiedNot specifiedNot specified
372Republic of ArmeniaGlobal FundMYLAN LABORATORIES LTDEmtricitabine+Tenofovir - FDC200mg+300mg tab0.17586400305.25288015120partnership for supply. chain management (PFSCM)2016NoNoNot specified
373Republic of PolandGovernmentGilead SciencesTruvadaEmtricitabine+Tenofovir - FDC200mg+300mg tab15.703345000030471.1150007066500Krajowe Centrum ds. AIDS2016Not specifiedYesNot specified
374Russian FederationGovernmentGilead SciencesTruvadaEmtricitabine+Tenofovir - FDC200mg+300mg tab6.97339897030209.23299690150.812015Not specifiedNot specifiedNot specified
375UkraineGlobal FundMacleods Pharmaceuticals LtdТенохопEmtricitabine+Tenofovir - FDC200mg+300mg tab0.1787774990305.3625833138464.882016YesYesYes
376GeorgiaNCDC GeorgiaMYLAN LABORATORIES LTDTruvadaEmtricitabine+Tenofovir - FDC200mg+300mg tab0.175246660305.25822243165.5partnership for supply. chain management (PFSCM)2016YesYesYes
377GeorgiaNCDC GeorgiaArcolab LTDTruvadaEmtricitabine/Tenofovir Disoproxil Fumarate200mg+300mg tab0.166780301030526767133835partnership for supply. chain management (PFSCM)2016YesYesYes
378Republic of PolandGovernmentGilead SciencesTruvadaEmtricitabine/Tenofovir Disoproxil Fumarate200mg+300mg tab15.70318000030471.0960002826540Krajowe Centrum ds. AIDS2016YesYesNot specified
379Russian FederationGovernmentRocheFuzeonEnfuvirtide108mg/ml infusion solution 1 ml1617940---2870402016YesYesNot specified
380Republic of LatviaGovernmentRocheFuzeonEnfuvirtide108mg/ml infusion solution 1 ml24.557760601473.4611473.462015Not specifiedNot specifiedNot specified
381Republic of LatviaGovernmentRocheFuzeonEnfuvirtide108mg/ml infusion solution 1 ml27.4897840601649.381423091.32National Health Service (NHC)2016Not specifiedNot specifiedNot specified
382Republic of PolandGovernmentRocheFuzeonEnfuvirtide108mg/ml infusion solution 1 ml26.5615480601593.69812749.52Krajowe Centrum ds. AIDS2016YesYesNot specified
383Russian FederationGovernmentRocheFuzeonEnfuvirtide108mg/ml infusion solution 1 ml18.170326940601090.22449489508.782015Not specifiedNot specifiedNot specified
384Republic of PolandGovernmentRocheFuzeonEnfuvirtide108mg/ml infusion solution 1 ml27.75120060166520333002015Not specifiedNot specifiedNot specified
385Republic of PolandGovernmentJohnson & JohnsonIntelenceEtravirine200mg tab6.69154050060401.49675271005.752015Not specifiedNot specifiedNot specified
386GeorgiaGlobal FundJanssenEtravirine100mg tab4.791757601205754827600partnership for supply. chain management (PFSCM)2015Not specifiedNot specifiedNot specified
387Republic of LatviaGovernmentJanssen-Cilag Internarional NVIntelenceEtravirine100mg tab3.98633480120478.362913872.44National Health Service (NHC)2016Not specifiedNot specifiedNot specified
388Republic of PolandGovernmentJanssenIntelenceEtravirine200mg tab5.9022100060354.12350123942Krajowe Centrum ds. AIDS2016Not specifiedNot specifiedYes
389UkraineGovernmentJanssenIntelenceEtravirine100mg tab2.887623880120346.5119968955.492016YesYesYes
390Russian FederationGovernmentJanssenIntelenceEtravirine200mg tab4.5567113640060273.41894051781962016YesYesYes
391UkraineGovernmentJanssenEtravirine100mg tab2.892223880120347.0619969064.942015Not specifiedNot specifiedNot specified
392GeorgiaNCDC GeorgiaJanssenIntelenceEtravirine100mg tab2.570801203005917700partnership for supply. chain management (PFSCM)2016YesYesYes
393Russian FederationGovernmentJohnson & JohnsonIntelenceEtravirine100mg tab2.7487454440120329.85378712491422015Not specifiedNot specifiedNot specified
394Republic of PolandGovernmentJanssenIntelenceEtravirine100mg tab6.08472100060365.08350127778Krajowe Centrum ds. AIDS2016Not specifiedNot specifiedYes
395Republic of PolandGovernmentJohnson & JohnsonIntelenceEtravirine200mg tab6.69151800060401.493001204472015Not specifiedNot specifiedNot specified
396Republic of LatviaGovernmentJohnson & JohnsonIntelenceEtravirine100mg tab3.5232120120422.791422.792015Not specifiedNot specifiedNot specified
397Russian FederationGovernmentJohnson & JohnsonIntelenceEtravirine200mg tab5.4245279966060325.4746661151867562015Not specifiedNot specifiedNot specified
398Republic of PolandGovernmentJanssenEdurantEtravirine100mg tab6.08472100060365.08350127778Krajowe Centrum ds. AIDS2016Not specifiedNot specifiedNot specified
399Russian FederationGovernmentViiV HealthcareTelzirFosamprenavir50mg/ml oral solution 225ml60.212608160.212608157027.692015Not specifiedNot specifiedNot specified
400Republic of PolandGovernmentGlaxoSmithKlineTelzirFosamprenavir700mg tab5.5833120060335206700Krajowe Centrum ds. AIDS2016YesNot specifiedNot specified
401Russian FederationGovernmentViiV HealthcareTelzirFosamprenavir700mg tab2.7628440601621047416967882016YesYesNot specified
402Republic of LatviaGovernmentViiv Healthcare UK LimitedTelzirFosamprenavir700mg tab5.5505246060333.034113654.23National Health Service (NHC)2016Not specifiedNot specifiedNot specified
403Russian FederationGovernmentViiV HealthcareTelzirFosamprenavir700mg tab3.3357214368060200.143572871506022015Not specifiedNot specifiedNot specified
404Republic of LatviaGovernmentViiV HealthcareTelzirFosamprenavir700mg tab4.87336060292.41292.42015Not specifiedNot specifiedNot specified
405Republic of PolandGovernmentGlaxoSmithKlineTelzirFosamprenavir700mg tab5.5833120060335206700Krajowe Centrum ds. AIDS2016YesYesNot specified
406Russian FederationGovernmentViiV HealthcareTelzirFosamprenavir50mg/ml oral solution 225ml42.39230142.392309749.72016YesYesNot specified
407UkraineGovernmentCipla Ltd